Evidence map›Paper›PMID 20018725›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis.

Armen Parsyan, David Shahbazian, Yvan Martineau, Emmanuel Petroulakis, Tommy Alain, Ola Larsson, Geraldine Mathonnet, Gritta Tettweiler, Christopher U Hellen, Tatyana V Pestova and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Armen ParsyanDepartment of Biochemistry, Faculty of Medicine and Goodman Cancer Center, McGill University, Montreal, Quebec, Canada.
David Shahbazian
Yvan Martineau
Emmanuel Petroulakis
Tommy Alain
Ola Larsson
Geraldine Mathonnet
Gritta Tettweiler
Christopher U Hellen
Tatyana V Pestova
Yuri V Svitkin
Nahum Sonenberg
McGill University · CASUNY Downstate Health Sciences University · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Translational control plays an important role in cell growth and tumorigenesis. Cap-dependent translation initiation of mammalian mRNAs with structured 5'UTRs requires the DExH-box protein, DHX29, in vitro. Here we show that DHX29 is important for translation in vivo. Down-regulation of DHX29 leads to impaired translation, resulting in disassembly of polysomes and accumulation of mRNA-free 80S monomers. DHX29 depletion also impedes cancer cell growth in culture and in xenografts. Thus, DHX29 is a bona fide translation initiation factor that potentially can be exploited as a target to inhibit cancer cell growth.

Indexed as

Cell Proliferation5' Untranslated RegionsAnimalsDown-RegulationHeLa CellsHumansMiceMice, NudeNeoplasmsNeoplasm TransplantationPeptide Chain Initiation, TranslationalRibosome Subunits, Small, EukaryoticRNA HelicasesRNA InterferenceRNA, MessengerRNA, Small Interfering5' Untranslated RegionsDHX29 protein, humanRNA HelicasesRNA, MessengerRNA, Small Interfering

Identifiers

PMID20018725
PMCPMC2799747
OpenAlexW2055427321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.